相关实验视频
Updated: Jan 14, 2026

06:16
Preparation Of Gushukang GSK Granules for In Vivo and In Vitro Experiments
Published on: May 9, 2019
8.0K
SGLT2 抑制剂,骨代谢生物标志物和骨质疏松症风险:孟德尔的随机化研究
Xin Wang1, Yibing Chen1, Ziyang Cheng1
1Shandong University of Traditional Chinese Medicine First Clinical Medical College, Jinan, 250014, People's Republic of China.
Experimental gerontology
|October 20, 2025
概括
-葡萄糖共运输体2 (SGLT2) 抑制剂可能会增加骨质疏松症的风险,即使骨矿物质密度更高. 总体没有调解这种效果,这表明其他途径也参与其中.
科学领域:
- 药物基因组学 药物基因组学
- 骨的新陈代谢 骨的新陈代谢
- 内分泌学 在内分泌学.
背景情况:
- 关于SGLT2抑制剂和骨质疏松症风险存在争议.
- 影响骨健康的潜在代谢途径尚未完全理解.
- SGLT2 抑制剂可能会影响骨代谢生物标志物,影响骨折风险.
研究的目的:
- 研究SGLT2抑制与骨质疏松症风险之间的因果关系.
- 评估骨代谢标志物在这种关联中的调解作用.
- 探索可能的途径,将SGLT2抑制与骨脆弱性联系起来.
主要方法:
- 采用了两个样本,两个步骤的门德尔随机化 (MR) 设计.
- 用于SGLT2抑制和HbA1c水平的利用基因变异 (SNP).
- 分析了17个骨生物标志物的影响及其对骨质疏松症的后续影响.
主要成果:
- 基因预测的SGLT2抑制与骨质疏松症风险增加 (OR 1.01) 和更高的骨矿物质密度 (BMD) 有着适度的关联.
- 总和介质素-6是与骨质疏松症相关的唯一标志物.
- 通过SGLT2抑制减少总丸激素并没有显著调节骨质疏松症风险.
结论:
- 尽管增加了BMD,但SGLT2抑制与骨质疏松症风险增加有遗传关联.
- 总丸激素不太可能是这种SGLT2抑制-骨质疏松症联系的调解者.
- 需要进一步的研究来阐明驱动SGLT2抑制剂相关骨脆弱性的机制.
相关概念视频
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Glucose Transporters
27.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.2K
Dipeptidyl Peptidase 4 Inhibitors
581
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
581
Study Designs in Epidemiology
878
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
878

